Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Obesity and dyslipidemia.

Barbara V Howard1, Giacomo Ruotolo, David C Robbins

  • 1MedStar Research Institute, 6495 New Hampshire Avenue, Suite 201, Hyattsville, MD 20783, USA. barbara.v.howard@medstar.net

Endocrinology and Metabolism Clinics of North America
|January 9, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Carotid artery atherosclerosis, MRI-defined structural brain abnormalities, and cognitive performance in elderly American Indians: The Strong Heart Study.

Frontiers in epidemiology·2025
Same author

Initiating Research in Indian Country: Lessons From the Strong Heart Study.

Preventing chronic disease·2025
Same author

Epidemiology of Head Injury and Associations with Clinical and Neuropsychological Test Scores in Older American Indians: Data from the Strong Heart Study.

Journal of racial and ethnic health disparities·2024
Same author

Electronic Monitoring of Mom's Schedule (eMOMS™): A Feasibility Randomized Controlled Trial Targeting Postpartum Weight Retention and Breastfeeding Duration Among Populations With Overweight/Obesity.

Journal of human lactation : official journal of International Lactation Consultant Association·2024
Same author

Circulating Sphingolipids and All-Cause Mortality: The Strong Heart Family Study.

Journal of the American Heart Association·2024
Same author

Evidence-based screening, clinical care and health education recommendations for Alaska Native peoples with prediabetes living in southcentral Alaska: findings from the Alaska EARTH follow-up study.

International journal of circumpolar health·2024
Same journal

Navigating Adrenal Disease: A Comprehensive, Practical Guide for the Clinician.

Endocrinology and metabolism clinics of North America·2026
Same journal

Adrenal Disorders in Pregnancy.

Endocrinology and metabolism clinics of North America·2026
Same journal

Diagnosis and Management of Adrenocortical Carcinoma.

Endocrinology and metabolism clinics of North America·2026
Same journal

Pheochromocytomas and Paragangliomas.

Endocrinology and metabolism clinics of North America·2026
Same journal

Hereditary Conditions Associated with Adrenocortical Carcinoma, Pheochromocytoma, and Other Adrenal Tumors: Genetic Testing and Management Recommendations.

Endocrinology and metabolism clinics of North America·2026
Same journal

Primary Bilateral Macronodular Adrenal Hyperplasia.

Endocrinology and metabolism clinics of North America·2026
See all related articles

Obesity causes dyslipidemia, marked by high triglycerides and low HDL. Lifestyle changes like weight loss and exercise can improve lipid profiles and reduce cardiovascular disease risk in obese individuals.

Area of Science:

  • Metabolic disorders
  • Cardiovascular health
  • Obesity research

Background:

  • Obesity is linked to dyslipidemia, characterized by elevated triglycerides, reduced HDL cholesterol, and altered LDL particle composition.
  • This metabolic dysfunction is closely associated with insulin resistance in obese populations.
  • The specific roles of insulin resistance versus overall body fat in these lipoprotein changes require further human studies.

Purpose of the Study:

  • To elucidate the pathogenesis of obesity-related dyslipidemia.
  • To understand the metabolic mechanisms driving lipoprotein alterations in obese individuals.
  • To differentiate the contributions of insulin resistance and body fat to dyslipidemia.

Main Methods:

  • Review of existing literature on obesity, dyslipidemia, and cardiovascular disease.

Related Experiment Videos

  • Analysis of metabolic pathways and lipoprotein changes.
  • Emphasis on human studies for clinical relevance.

    • Main Results:

    • Obesity-induced dyslipidemia involves increased triglycerides, decreased HDL, and atherogenic small, dense LDL particles.
    • These lipid abnormalities significantly contribute to atherosclerosis and cardiovascular disease (CVD) risk in obese individuals.
    • Weight loss and exercise demonstrably improve dyslipidemia and lower CVD risk, even without complete weight normalization.

    Conclusions:

    • Obesity-related dyslipidemia is a major risk factor for atherosclerosis and CVD.
    • Interventions like weight loss and exercise are effective in mitigating dyslipidemia and reducing cardiovascular risk.
    • Targeted lipid-lowering therapy is recommended for obese individuals when necessary.